Optomed Oyj (HEL:OPTOMED)
Finland · Delayed Price · Currency is EUR 1.592
+0.042 (2.71%)
Jul 28, 2026, 4:30 PM EET
Optomed Oyj Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 16.43 | 17.1 | 15.04 | 15.1 | 14.66 | 14.85 | |
Revenue Growth | 4.39% | 13.67% | -0.40% | 3.00% | -1.28% | - |
Cost of Revenue | 5.94 | 6.22 | 5.37 | 4.86 | 5.45 | 5.1 |
Gross Profit | 10.48 | 10.87 | 9.67 | 10.24 | 9.21 | 9.75 |
Selling, General & Admin | 9.82 | 9.95 | 8.93 | 8.7 | 8.83 | 8.7 |
Depreciation & Amortization Expenses | 2.58 | 2.52 | 2.5 | 2.19 | 3.15 | 2.78 |
Other Operating Expenses | 4.15 | 4.45 | 4.19 | 3.33 | 2.34 | 3.05 |
Total Operating Expenses | 16.55 | 16.92 | 15.62 | 14.22 | 14.31 | 14.53 |
Operating Income | -6.07 | -6.04 | -5.96 | -3.97 | -5.1 | -4.78 |
Interest Income | 0.84 | 0.58 | 1.22 | 0.48 | 0.57 | 0.72 |
Interest Expense | -1.01 | -1.26 | -0.78 | -1.02 | -1.02 | -0.26 |
Total Non-Operating Income (Expense) | -0.17 | -0.68 | 0.44 | -0.55 | -0.46 | 0.45 |
Pretax Income | -6.24 | -6.72 | -5.52 | -4.52 | -5.55 | -4.33 |
Provision for Income Taxes | -0.08 | -0.08 | -0.07 | -0.08 | -0.08 | -0.08 |
Net Income | -6.16 | -6.64 | -5.45 | -4.44 | -5.47 | -4.25 |
Net Income to Common | -6.16 | -6.64 | -5.45 | -4.44 | -5.47 | -4.25 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 20 | 20 | 19 | 17 | 15 | 13 |
Shares Outstanding (Diluted) | 20 | 20 | 19 | 17 | 15 | 13 |
Shares Change | 7.90% | 6.08% | 11.78% | 14.11% | 8.92% | - |
EPS (Basic) | -0.31 | -0.34 | -0.29 | -0.27 | -0.37 | -0.32 |
EPS (Diluted) | -0.31 | -0.34 | -0.29 | -0.27 | -0.37 | -0.32 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.74 | -3.04 | -1.87 | -0.83 | -3.15 | -3.4 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.24 | -0.15 | -0.10 | -0.05 | -0.22 | -0.25 |
Gross Margin | 63.82% | 63.61% | 64.27% | 67.83% | 62.83% | 65.64% |
Operating Margin | -36.96% | -35.34% | -39.61% | -26.32% | -34.77% | -32.19% |
Profit Margin | -37.50% | -38.84% | -36.24% | -29.41% | -37.33% | -28.61% |
FCF Margin | -28.83% | -17.80% | -12.44% | -5.48% | -21.49% | -22.91% |
EBITDA | -3.49 | -3.53 | -3.46 | -1.78 | -1.95 | -2.09 |
EBITDA Margin | -21.25% | -20.62% | -22.99% | -11.79% | -13.32% | -14.08% |
EBIT | -6.07 | -6.04 | -5.96 | -3.97 | -5.1 | -4.78 |
EBIT Margin | -36.96% | -35.34% | -39.61% | -26.32% | -34.77% | -32.19% |
Effective Tax Rate | 1.23% | 1.15% | 1.20% | 1.75% | 1.42% | 1.80% |